🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Now online - check out this video from Karin Strube where Juliane Walz introduces our new phase I #ClinicalTrial for an #immunopeptidomics-based #peptide #vaccine for #patients with #AML. youtube.com/watch?v=tFuY4X…

👏#Congrats to our iFIT 2024 class who succesfully mastered the "Excellence in International #STEM #Communication, Productivity and #Career Skills" program by coach Dr. Paul Charlton! Equipped with the skillset to face the challenges of their future scientific careers!

Thanks to Bruker for organizing a great local event in #Tübingen! Naomi gave a great talk about #peptide based #Immunotherapy! Further impressions: linkedin.com/messaging/thre…

Congratulations to yacine.maringer and Jonas Rieth for successfully defending their #PhD thesis! What a great journey we had and still have with you!🥂

Just a quick reminder for today's lecture within Universität Tübingen #summer #university! Join Bettina Weigelin on her fascinating journey into the world of #cancer #immunotherapies!

Another great white party in the heart of #Tübingen together with Translational Immunology! 🥂 We officially announce the ennoblement of the Lady and Lord of the Glen!

👀#SneakPeek! Juliane Walz had a great time during today's "meeting" with host Jennifer Raffler! We cannot reveal much, but keep an eye on the social media channels of Universität Tübingen next week! 🎙️🎧 #cancerresearch #immunotherapy #cancervaccine

😃Happy to share the next episode of Universität Tübingen & Tübingen University Excellence Projects🎙️ #podcast "Key to My Research" with iFIT participation! In this episode Peptide-based Immunotherapy explains the benefits of peptid-based #immunotherapy and how #cancer peptide #vaccines work! 🎧Tune in: keytomyresearch.podbean.com/e/deep-dive-ca…

Great talks at the 6th ForTra Workshop for Translational Research.Else Kröner Fresenius Center for Digital Health

Today we had the honor to welcome Marna Davis the founder of the #fibrolammelar #carcinoma Fibrolamellar Cancer. She brought us a big surprise: The #approval of our grant to fund a #clinicalstudy with our fusion-based peptide vaccine in FLC #patients.

🥳#Congrats to our spokesperson Juliane Walz! 🏆 She received the #Research #Award from the Robert Pfleger Foundation! The #prize is endowed with 50,000€ and is awarded every two years. The Foundation honors the achievements of Prof. Walz regarding peptid-based #immunotherapy

Proud to announce that Juliane Walz received the Robert Pfleger Foundation #research #award for peptide-based #immunotherapy of #tumors and #infections! Congrats also to Marion Marion Subklewe for her award! 🚀

Congratulations to Susanne Jung on winning the poster #award at this year's #DGHO24 meeting in #Basel. She was introducing our #clinicaltrial using #peptide-based #vaccination for the treatment of #fibrolamellar #hcc #patients. DGHO e. V.

👏Congrats Peptide-based Immunotherapy! 🏆Juliane received the SWISS BRIDGE Award 2024! 🇨🇭The prize money of 250,000 Swiss francs supports the implementation of her clinical study investigating new, promising approaches to treating #cancer with #immunotherapies.

We are #hiring! 🚀 Join our #bioinformatics team in a truly #interdisciplinary environment driving #immunopeptidomics analyses and pipeline development with direct impact on advancing patient treatment! Check out the full job description: jobs.medizin.uni-tuebingen.de/Job/5336/Bioin…

New #JITC article: Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression bit.ly/4ejyxSZ Malte Roerden Kevin Litchfield Stefani Spranger #SITC24

🤔You are a 👩‍🔬 👨‍🔬 #Bioinformatician and have a soft spot for working on mass spectrometry-based #immunopeptidomics and the characterization of #tumor-associated #antigens? 🤗Then become part of Peptide-based Immunotherapy and apply now! ➡️jobs.medizin.uni-tuebingen.de/Job/5336/Bioin… #Job #jobopportunities

We are more than happy that our publication is accepted by Editor - Neuro-Oncology Advances Fantastic collaboration with Peptide-based Immunotherapy academic.oup.com/noa/advance-ar… Check it out ;) Hertie-Zentrum für Neurologie Tübingen University Excellence Projects

Thrilled about this symposium i3S-Instituto de Investigação e Inovação em Saúde featuring influential scientists & word-class research in #immunoengineering: Immunotherapies by Jeff Hubbell, Peptide-based Immunotherapy Peptide-based Immunotherapy, Cell Reprogramming in Immunity Pereira Lab, Regenerative Immunotherapies @jhelisseeff.bsky.social!